Clinical epidemiology of fulminant hepatitis in Japan

スポンサーリンク

概要

• 論文の詳細を見る
• 2008-11-01

著者

• TAKIKAWA YASUHIRO

  First Department of Internal Medicine, Iwate Medical University

• SUZUKI KAZUYUKI

  First Department of Internal Medicine, Iwate Medical University

• Takikawa Yasuhiro

  First Department Of Internal Medicine And Open Research Center Advanced Medical Science Center Iwate

• Suzuki Kazuyuki

  First Department Of Internal Medicine Iwate Medical University

関連論文

• A male patient with severe acute hepatitis who was domestically infected with a genotype H hepatitis B virus in Iwate, Japan
• Primary Carcinoid Tumor of the Liver : A Case Report
• Ursodeoxycholic acid inhibits histamine release from rat peritoneal mast cells
• Changes in liver function parameters after percutaneous radiofrequency ablation therapy in patients with hepatocellular carcinoma
• Evaluation of newly developed combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma with portal venous invasion : preliminary results
• Seroprevalence of anti-HEV and epidemiological features in hog raising area and non hog raising area
• A case of acute hepatitis E associated with multidrug hypersensitivity and cytomegalovirus reactivation
• Interleukin-17 as a new marker of severity of acute hepatic injury
• Clinical epidemiology of fulminant hepatitis in Japan before the substantial introduction of liver transplantation : an analysis of 1309 cases in a 15-year national survey
• Proinflammatory cytokines up-regulate synthesis and secretion of urinary trypsin inhibitor in human hepatoma HepG2 cells
• Epidemiological and clinical study of sporadic acute hepatitis E caused by indigenous strains of hepatitis E virus in Japan compared with acute hepatitis A
• Contrast-Enhanced Ultrasonography Using Levovist : Usefulness of Diagnosis of Small Focal Nodular Hyperplasia Lesions
• Serum levels of soluble Fas ligand in patients with acute and fulminant hepatitis : relationship with soluble Fas, tumor necrosis factor α and TNF receptor-1
• Serum hyaluronate in patients with acute and fulminant hepatitis
• Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis
• Regional differences in cerebral glucose metabolism in cirrhotic patients with subclinical hepatic encephalopathy using positron emission tomography
• Serum soluble CD44 levels in patients with acute and fulminant hepatitis Relationship with serum hyaluronate levels
• Preliminary note Decreased brain concentrations of choline and acetylcholine in mice with thioacetamide-induced acute liver failure
• Pretreatment hepatitis C virus dynamics for predicting virological response to interferon-α2b monotherapy in patients with chronic hepatitis C virus infection
• Development of quantitative neuropsychological tests for diagnosis of subclinical hepatic encephalopathy in liver cirrhosis patients and establishment of diagnostic criteria-multicenter collaborative study in Japanese
• Nucleotide Substitutions of Hepatitis E Virus Genomes Associated with Fulminant Hepatitis and Disease Severity
• Quantitative Measurement of Thymidylate Synthase and Dihydropyrimidine Dehydrogenase mRNA Level in Gastric Cancer by Real-time RT-PCR
• Induction of Bcl-xL is a possible mechanism of anti-apoptotic effect by prostaglandin E2 EP4-receptor agonist in human hepatocellular carcinoma HepG2 cells
• Apoptotic hepatocellular carcinoma HepG2 cells accelerate blood coagulation
• Liver Fat Content Measured by Magnetic Resonance Spectroscopy at 3.0 Tesla Independently Correlates with Plasminogen Activator Inhibitor-1 and Body Mass Index in Type 2 Diabetic Subjects
• Prostaglandin E2 receptor EP4 agonist induces Bcl-xL and independently activates proliferation signals in mouse primary hepatocytes
• Marked improvement in the resolution of, and survival rates in, spontaneous bacterial peritonitis
• Branched-chain amino acid treatment in patients with liver cirrhosis
• How to select BCAA preparations
• Beneficial effect of Cyclosporin A on acute hepatic injury induced by galactosamine and lipopolysaccharide in rats
• Analysis of the genotype-determining region of hepatitis A viral RNA in relation to disease severities
• IMPROVEMENTS IN THE PATHOPHYSIOLOGY AND THE QOL OF LIVER CIRRHOSIS BY NUTRITIONAL TREATMENT WITH BRANCHED-CHAIN AMINO ACIDS
• Fasting plasma ghrelin levels reflect malnutrition state in patients with liver cirrhosis
• Serum leptin concentrations in liver cirrhosis : relationship to the severity of liver dysfunction and their characteristic diurnal profiles
• Analysis of SMAD4/DPC4 gene alterations in multiploid colorectal carcinomas
• Immunoreactivity of antimitochondrial autoantibodies in Japanese patients with primary biliary cirrhosis
• Brain glutamine and glutamate levels in patients with liver cirrhosis : assessed by 3.0-T MRS
• NEW ENDOSCOPIC TECHNIQUE TO CLOSE LARGE MUCOSAL DEFECTS AFTER ENDOSCOPIC MUCOSAL RESECTION IN PATIENTS WITH GASTRIC MUCOSAL TUMORS
• ENDOSCOPIC CLOSURE OF MUCOSAL DEFECTS WITH METALLIC CLIPS AFTER ENDOSCOPIC MUCOSAL RESECTION IN PATIENTS WITH INTRAMURAL TUMORS OF THE STOMACH : A RETROSPECTIVE STUDY
• A novel prostaglandin E receptor subtype agonist, 0N0-4819, attenuates acute experimental liver injury in rats
• Clinical epidemiology of fulminant hepatitis in Japan
• Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma

もっと見る 閉じる

スポンサーリンク